The Importance of Genetics and Biomarkers in the Changing Treatment Landscape
Ovarian Cancer Research Alliance hosted a free online seminar for the ovarian and gynecologic cancer community on September 19, 2024, to share important information about genetics, biomarkers, and the latest in precision medicine for ovarian and related gynecologic cancers. Dr. Barbara Norquist of the University of Washington and Dr. Ying Liu of Memorial Sloan Kettering Cancer Center answered questions live, and a patient panel shared their perspectives on survivorship and clinical trial participation.
This event was made possible with support from AstraZeneca.